fda tirzepatide injection shortage resolved october 2 2024 GLP-1 Drugs: Removes Lilly's Zepbound® and Mounjaro® (tirzepatide injection) from its Drug List GLP-1 Drugs: Brand Companies Push

They increase the expression of beta-adrenergic receptors, leading to enhanced cardiac output

Penn study finds taking semaglutide for weight management does not increase risk of depression or suicidal behavior in people without known major psychopathology

25, UF researchers studied Medicare claims data of older adults with Type 2 diabetes to assess their risk of depression while undergoing treatment with either GLP-1RAs, SGLT2is or DPP4is

Strength training or resistance exercises help preserve and even build muscle mass, ensuring that most of the weight lost is from fat, not lean tissue

This narrative review highlights the main pharmacological strategies currently approved for the treatment of MASLD

Generally, you can expect the following results: Lower blood sugar and blood pressure Weight loss, which typically begins within the first few weeks of treatment and continues over time Reduced appetite, making it easier to maintain a healthy diet Improved cardiovascular health and a decreased risk of heart-related complications While it offers exceptional results, semaglutide is not a magic cure-all